Increase in prostate needle biopsy-linked infection in N.Y.

April 18, 2017

(HealthDay)—Infectious complications after prostate needle biopsy increased from 2011 to 2014 across New York State, according to a study published in the April issue of The Journal of Urology.

Using the New York Statewide Planning and Research Cooperative System, Joshua A. Halpern, M.D., from the Weill Cornell Medical College in New York City, and colleagues identified prostate needle biopsies performed between 2011 and 2014 via the transrectal and transperineal approach (9,472 and 421 patients, respectively).

The researchers found that with time there was a decrease in ambulatory use of prostate needle biopsy (P < 0.01). For prostate needle biopsy, the most common indication was elevated prostate-specific antigen (53.2 percent of patients), followed by active surveillance for cancer, abnormal digital rectal examination, and atypia (26.7, 2.6, and 1.6 percent, respectively). During the study period the rate of prostate needle biopsy-associated infection increased from 2.6 to 3.5 percent (P = 0.02). The complication rate among the 777 repeat prostate needle biopsies was comparable to that of initial prostate needle biopsy. Patient race, procedure year, diabetes (odds ratio, 1.92), transrectal approach (odds ratio, 3.48), and recent hospitalization (odds ratio, 2.03) were significantly associated with infection on multivariable analysis.

"With higher complications using the transrectal approach and minimal utilization of targeted antibiotic prophylaxis, further efforts should focus on the evaluation and implementation of these strategies to reduce post-prostate biopsy complications nationally," the authors write.

Explore further: Targeted antibiotics may help protect against infections in men being tested for prostate cancer

More information: Abstract
Full Text
Editorial (subscription or payment may be required)

Related Stories

Targeted antibiotics may help protect against infections in men being tested for prostate cancer

February 1, 2016
A new review indicates that antimicrobial therapy given before clinicians take transrectal ultrasound-guided prostate biopsies to diagnose prostate cancer may lead to lower rates of sepsis, a potentially life-threatening ...

Less intense surveillance OK for some prostate cancer cases

December 23, 2016
(HealthDay)—Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance, according to a study published in the January issue of The Journal of Urology.

MRI has a role to play after negative prostate biopsy

December 16, 2016
(HealthDay)—Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published in the December issue ...

Repeat prostate biopsy rounds yield cancer cases

April 13, 2015
(HealthDay)—Among a group of men with an initial negative prostate biopsy, clinically significant cancer is still found in subsequent repeat sampling rounds, according to a study published in the April issue of The Journal ...

Guidelines developed for prostate MRI after negative biopsy

November 18, 2016
(HealthDay)—In a consensus statement from the American Urological Association and Society of Abdominal Radiology, published in the December issue of The Journal of Urology, guidelines are presented for prostate magnetic ...

Is MRI the 'mammography' of prostate cancer screening?

March 27, 2017
(HealthDay)—MRI screening might greatly reduce overdiagnosis and overtreatment of prostate cancer in older men, a preliminary study suggests.

Recommended for you

Scientists discover chemical which can kill glioblastoma cells

August 15, 2018
Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown.

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...

RUNX proteins act as regulators in DNA repair, study finds

August 15, 2018
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) ...

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.